Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYSTER trial of intracervical terlipressin to reduce gas embolism during hysteroscopic surgery
NL-OMON28576Active, not recruiting
- Sponsor
- OLVG
- Start
- Apr 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in menstrual disorders and Fibromyoma (LM) comparing Intracervical terlipressin with Placebo (2 arms). Primary endpoints: Incidence of venous or paradoxical gas embolism, Severity of gas embolism and 1 more. Started Apr 2014; status: active, not recruiting.
02
Drugs
terlipressin
03
Conditions
menstrual disordersFibromyoma (LM)
Beyond the preview
Go deeper on NL-OMON28576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28576.